In this section of the General Tradeshow News Site, you'll find event-related news releases from PR Newswire. The releases are listed in chronological order and are archived by month and year.
Webinar introduces strategic messaging framework and step-by-step process for building an industry narrative that helps organizations stand apart from the crowd
DevOps Data Scientist and Container Systems Expert to Lend Expertise, Insights and Guidance to Help Electric Cloud Accelerate Organizational Adoption of DevOps
- The Mentor® Xpedition® High-Density Advanced Packaging (HDAP) flow is the industry's first comprehensive solution for the design and verification of today's leading-edge IC package designs.
Thermo Scientific InsuQuant Mass Spectrometric Immunoassay Kit provides an innovative solution for highly sensitive pre-analytical protein purification
-- Preliminary results from phase 1 study demonstrate a 46.7 percent overall response rate and 100 percent disease control rate with smart chemotherapy DS-8201 in a subgroup analysis of HER2-expressing metastatic breast cancer pre-treated with T-DM1 and pertuzumab
- BLU-285 receives Breakthrough Therapy Designation for the treatment of patients with unresectable or metastatic GIST harboring the PDGFRα D842V mutation -
- Nintedanib plus standard chemotherapy (pemetrexed/cisplatin) demonstrated a 46% reduction in the risk of disease progression in patients with inoperable malignant pleural mesothelioma (MPM) compared to placebo plus standard chemotherapy
- Data show 59 percent progression free survival and 74 percent overall survival in CLL/SLL patients treated with IMBRUVICA, with high-risk patients trending to have the most favorable outcome[1]
Updated analyses of the pivotal Phase 3 POLLUX and CASTOR studies featured as an oral presentation at the American Society of Clinical Oncology (ASCO) 2017 Annual Meeting (Abstract 8006)